Hvivo (HVO)

Sector:

Health Care

Index:

FTSE AIM All-Share

27.25p
   
  • Change Today:
    -0.25p
  • 52 Week High: 30.50
  • 52 Week Low: 14.25
  • Currency: UK Pounds
  • Shares Issued: 680.37m
  • Volume: 601,061
  • Market Cap: £185.40m

Venn Life Sciences expecting revenues to double

By Josh White

Date: Friday 08 Jan 2016

LONDON (ShareCast) - (ShareCast News) - Venn Life Sciences was working to please investors on Friday, revealing its expectations for the year ahead of its full-year results.
The AIM-listed drug development services company said revenues for the full year to 31 December were expected to be at least double the previous year, when they were €4.9m (£3.68m).

Venn said it was well-funded for future growth, and had cash reserves of €3.4m, with the business now generating free cashflows.

"We have now more than doubled our book of business in successive years and built a strong foundation on which we can deliver further growth," said CEO Tony Richardson.

"The addition of drug development and early phase capabilities into our service offering will enable us to capture greater market share in 2016, and truly differentiate our position in the market."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Hvivo Market Data

Currency UK Pounds
Share Price 27.25p
Change Today -0.25p
% Change -0.91 %
52 Week High 30.50
52 Week Low 14.25
Volume 601,061
Shares Issued 680.37m
Market Cap £185.40m

Hvivo Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.51% below the market average95.51% below the market average95.51% below the market average95.51% below the market average95.51% below the market average
81.25% below the sector average81.25% below the sector average81.25% below the sector average81.25% below the sector average81.25% below the sector average
Price Trend
96.18% above the market average96.18% above the market average96.18% above the market average96.18% above the market average96.18% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income
94.72% below the market average94.72% below the market average94.72% below the market average94.72% below the market average94.72% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
41.80% above the market average41.80% above the market average41.80% above the market average41.80% above the market average41.80% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Hvivo Dividends

  Latest Previous
  Final Special
Ex-Div 18-Apr-24 04-May-23
Paid 20-May-24 09-Jun-23
Amount 0.20p 0.45p

Trades for 16-May-2024

Time Volume / Share Price
16:29 10,000 @ 27.24p
16:29 2,000 @ 27.24p
16:17 366 @ 27.28p
16:09 6,250 @ 27.28p
16:05 56,100 @ 27.00p

Hvivo Key Personnel

CEO Yamin Mo' Khan

Top of Page